Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Froniglutide in Idiopathic Inflammatory Myopathy
NCT05833711Phase 2Recruiting
- Sponsor
- ImmunoForge
- Start
- Sep 2023
- Primary completion
- Mar 2025
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of froniglutide in dermatomyositis (DM), polymyositis (PM), sponsored by ImmunoForge. Started Sep 2023; status: recruiting.
02
Drugs
froniglutide
03
Conditions
dermatomyositis (DM)polymyositis (PM)
Beyond the preview
Go deeper on NCT05833711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05833711.